Isobel Crabb

Isobel Crabb joined the Growth Investments team at Novo Holdings in July 2025. Prior to this, she was a Senior Consultant at Globe Life Sciences, advising life sciences companies and investors on commercial strategy, asset evaluation, and market analysis. She began her career in healthcare-focused equity research and sales, covering a broad range of subsectors across the healthcare industry. Isobel holds a degree in Natural Sciences from the University of Cambridge.